Clinical Study of 18F-FAPI-RGD in Ovarian Cancer

Launched by SICHUAN PROVINCIAL PEOPLE'S HOSPITAL · Sep 23, 2024

Keywords

ClinConnect Summary

Ovarian cancer is the malignant tumor with the highest mortality rate among women, and also the most intractable gynecological malignant tumor in clinical treatment. Its incidence rate and mortality are increasing year by year. China's incidence rate of ovarian cancer ranks first in the world.Due to the lack of typical clinical symptoms and effective screening tools in the early stage, more than 70% of patients were in advanced cancer when diagnosed,that is, there was peritoneal and/or distant metastasis. The mortality rate was high (mortality/incidence rate ratio was 60%) , the radical cur...

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria:• Age 18 and above• Patients who have been diagnosed with, or are clinically highly suspected of, Ovarian cancer and have had no other treatment within 3 months -
• • Exclusion Criteria:• Patients with a second primary tumor• Pregnant or breastfeeding• Severe liver or kidney disease•Claustrophobia or other PET/CT scan contraindications
• • -